BRAK Human

BRAK (CXCL14) Human Recombinant

CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.
The CXCL14 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT9538
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

BRAK Human, His

BRAK Human Recombinant (CXCL14), His-Tag

CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 88 amino acids and having a molecular mass of 10.66 kDa.
The Human BRAK contains a 10 a.a. fusion His tag at N-Terminus.
The BRAK is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT9605
Source
Escherichia Coli.
Appearance
Filtered White lyophilized (freeze-dried) powder.

BRAK Mouse

BRAK (CXCL14) Mouse Recombinant

CXCL14 Mouse Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.
The CXCL14 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT9676
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

BRAK Rat

BRAK (CXCL14) Rat Recombinant

CXCL14 Rat Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.
The CXCL14 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT9761
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

BRAK, also known as Chemokine (C-X-C motif) ligand 14 (CXCL14), is a small cytokine belonging to the CXC chemokine family. It was initially identified from breast and kidney cells in 1999. CXCL14 is a non-ELR (glutamic acid-leucine-arginine) chemokine with a broad spectrum of biological activities. It is classified under the CXC chemokine family, characterized by the presence of two cysteine residues separated by a single amino acid .

Biological Properties

CXCL14 is constitutively expressed in many normal tissues, particularly in epithelial cells. It is highly conserved across vertebrates, with human and mouse CXCL14 differing by only two amino acid residues. The expression of CXCL14 is significantly down-regulated or completely lost in many human cancer specimens and cancerous cell lines . Key biological properties include:

  • Expression Patterns: Constitutively expressed in normal tissues, especially in the epithelia.
  • Tissue Distribution: Widely expressed in normal tissues, particularly in breast and kidney cells .
Biological Functions

CXCL14 plays a crucial role in immune responses and pathogen recognition. It is involved in the regulation of immune cell migration and antimicrobial immunity. CXCL14 is chemotactic for monocytes and can activate these cells in the presence of inflammatory mediators such as prostaglandin-E2 (PGE2). It is also a potent chemoattractant and activator of dendritic cells, implicated in the homing of these cells, and can stimulate the migration of activated natural killer (NK) cells .

Modes of Action

The mechanisms of action of CXCL14 involve interactions with other molecules and cells, binding partners, and downstream signaling cascades. Although the identity of the receptor for CXCL14 remains obscure, it is known to induce intracellular signaling through G protein-coupled cell-surface receptors. CXCL14 inhibits angiogenesis, possibly by blocking endothelial cell chemotaxis .

Regulatory Mechanisms

The regulatory mechanisms controlling the expression and activity of CXCL14 include transcriptional regulation and post-translational modifications. CXCL14 expression can be inhibited by inflammatory stimuli such as tumor necrosis factor-alpha (TNF-α) and lipopolysaccharides (LPS) in epithelial tissues. Epigenetic mechanisms, such as DNA methylation, also play a role in the regulation of CXCL14 expression in cancer cells .

Applications

CXCL14 has several applications in biomedical research, diagnostic tools, and therapeutic strategies. It is used in various assays, including Western Blot, ELISA, and functional assays. CXCL14’s role in immune cell migration and antimicrobial immunity makes it a potential target for therapeutic strategies in cancer and inflammatory diseases .

Role in the Life Cycle

CXCL14 plays a role throughout the life cycle, from development to aging and disease. It is involved in immune surveillance, inflammation, and tumor development by regulating cell migration. The loss of CXCL14 expression in tumors may facilitate neovascularization and contribute to immunologic escape .

© Copyright 2024 Thebiotek. All Rights Reserved.